Kaskela Law LLC Announces Stockholder Investigation of Bristol-Myers Squibb Company - BMY
RADNOR, PA / ACCESSWIRE / February 6, 2019 / Kaskela Law LLC is investigating Bristol-Myers Squibb Company (″Bristol-Myers″ or the ″Company″) (NYSE: BMY ) of behalf of the Company’s stockholders.
Additional information about this investigation may be found at http://kaskelalaw.com/case/bristol-myers-squibb-company/.
On January 3, 2019, Bristol-Myers announced that it had entered into an agreement to acquire Celgene Corp. (NASDAQ: CELG). According to the announcement, Bristol-Myers has proposed exchanging 1 share of Bristol-Myers common stock, $50 in cash, and one contingent value right (″CVR″) for each share of Celgene common stock.
In connection with the proposed acquisition, Bristol-Myers has disclosed that it expects to issue approximately 700 million shares of common stock to Celgene stockholders, and that it will need approximately $36 billion in order to pay Celgene stockholders the cash amounts due to them under the proposed transaction, and for related fees and transaction costs.
Kaskela Law’s investigation seeks to determine whether the proposed transaction as structured is fair to Bristol-Myers and its stockholders, and whether Bristol-Myers stockholders are being provided with all required material information necessary to evaluate and vote on the proposed transaction.
Bristol-Myers stockholders are encouraged to contact Kaskela Law (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or via email at to discuss this investigation and their legal rights and options. Additional information about this investigation may be found at http://kaskelalaw.com/case/bristol-myers-squibb-company/.
Kaskela Law LLC exclusively represents stockholders in state and federal actions throughout the country. For additional information about Kaskela Law LLC please visit http://kaskelalaw.com/practice-areas/.
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
201 King of Prussia Road
Radnor, PA 19087
(888) 715 - 1740
(484) 258 - 1585
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC